Anticancer research
-
Anticancer research · May 2020
Randomized Controlled TrialA Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer.
Continuation maintenance therapy is standard for advanced nonsquamous non-small cell lung cancer; however, the optimal maintenance strategy has yet to be determined. ⋯ The median PFS was numerically better in the BEV+PEM arm, but the median OS was not significantly different among the three arms.